Seven-tesla magnetic resonance images of the substantia nigra in Parkinson disease

Annals of Neurology

Volumn 71, Issue 2, 2012, Pages 267-277

  Kwon, Dae Hyuk ^a   Kim, Jong Min ^b   Oh, Se Hong ^a   Jeong, Hye Jin ^a   Park, Sung Yeon ^a   Oh, Eung Seok ^b   Chi, Je Geun ^a,c   Kim, Young Bo ^a   Jeon, Beom S ^b   Cho, Zang Hee ^a  

^a Gachon University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHO PLANAR IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA; THREE DIMENSIONAL IMAGING;

AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84863229895     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22592     Document Type: Article

References (54)

1. Fearnley JM, Lees AJ,. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114 (pt 5): 2283-2301.
2. Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987; 2: 1219-1220. (Pubitemid 17156630)
3. Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 1988; 74: 199-205.
4. Drayer B, Burger P, Darwin R, et al. MRI of brain iron. AJR Am J Roentgenol 1986; 147: 103-110. (Pubitemid 16066336)
5. Rutledge JN, Hilal SK, Silver AJ, et al. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987; 149: 365-379. (Pubitemid 17104998)
6. Bartzokis G, Aravagiri M, Oldendorf WH, et al. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 1993; 29: 459-464. (Pubitemid 23112748)
7. Graham JM, Paley MN, Grünewald RA, et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000; 123 (pt 12): 2423-2431.
8. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999; 210: 759-767. (Pubitemid 29124039)
9. Cho ZH, Min HK, Oh SH, et al. Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-Tesla magnetic resonance imaging. J Neurosurg 2010; 113: 639-647.
10. Oikawa H, Sasaki M, Tamakawa Y, et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002; 23: 1747-1756. (Pubitemid 35304115)
11. Cho ZH, Oh SH, Kim JM, et al. Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T MRI. Mov Disord 2011; 26: 713-718.
12. Cho ZH, Kim YB, Han JY, et al. New brain atlas-mapping the human brain in vivo with 7.0T MRI and comparison with postmortem histology: will these images change modern medicine? Int J Imaging Syst Technol 2008; 18: 2-8.
13. Chen Z, Johnston LA, Kwon DH, et al. An optimised framework for reconstructing and processing MR phase images. Neuroimage 2010; 49: 1289-1300.
14. Cho ZH, Han JY, Hwang SI, et al. Quantitative analysis of the hippocampus using images obtained from 7.0 T MRI. Neuroimage 2010; 49: 2134-2140.
15. Abosch A, Yacoub E, Ugurbil K, Harel N,. An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 Tesla. Neurosurgery 2010; 67: 1745-1756.
16. Eapen M, Zald DH, Gatenby JC, et al. Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system. AJNR Am J Neuroradiol 2011; 32: 688-694.
17. Chung MK, Dalton KM, Shen L, et al. Weighted Fourier series representation and its application to quantifying the amount of gray matter. IEEE Trans Med Imaging 2007; 26: 566-581. (Pubitemid 46527336)
18. Chung MK, Nacewicz BM, Wang S, et al. Amygdala surface modeling with weighted spherical harmonics. In:, Dohl T, Sakuma I, Liao H, editors. The 4th international workshop on medical imaging and augmented reality (MIAR 2008). Berlin, Germany: Springer, 2008: 177-184.
19. Eritaia J, Wood SJ, Stuart GW, et al. An optimized method for estimating intracranial volume from magnetic resonance images. Magn Reson Med 2000; 44: 973-977.
20. Lehéricy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994; 15: 929-937. (Pubitemid 24153784)
21. Malykhin NV, Bouchard TP, Ogilvie CJ, et al. Three-dimensional volumetric analysis and reconstruction of amygdala and hippocampal head, body and tail. Psychiatry Res 2007; 155: 155-165. (Pubitemid 46874910)
22. Sofic E, Paulus W, Jellinger K, et al. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 1991; 56: 978-982. (Pubitemid 21922711)
23. Hirsch EC, Brandel JP, Galle P, et al. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 1991; 56: 446-451. (Pubitemid 21901982)
24. Good PF, Olanow CW, Perl DP,. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 1992; 593: 343-346.
25. Griffiths PD, Dobson BR, Jones GR, Clarke DT,. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 1999; 122 (pt 4): 667-673. (Pubitemid 29158775)
26. Antonini A, Leenders KL, Meier D, et al. T2 relaxation time in patients with Parkinson's disease. Neurology 1993; 43: 697-700. (Pubitemid 23121959)
27. Gorell JM, Ordidge RJ, Brown GG, et al. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995; 45: 1138-1143.
28. Damier P, Hirsch EC, Agid Y, Graybiel AM,. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 1999; 122 (pt 8): 1421-1436. (Pubitemid 29374121)
29. Damier P, Hirsch EC, Agid Y, Graybiel AM,. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999; 122 (pt 8): 1437-1448. (Pubitemid 29374122)
30. Björklund A, Lindvall O,. Dopamine-containing systems in the CNS. In:, Björklund A, Hökfelt T, editors. Classical transmitters in the CNS, part I. Handbook of chemical neuroanatomy. Vol 2. Amsterdam, the Netherlands: Elsevier, 1984: 55-122.
31. Lewis DA, Sesack SR,. Dopamine systems in the primate brain. In:, Bloom FE, Björklund A, Hökfelt T, editors. The primate nervous system, part I. Handbook of chemical neuroanatomy. vol 13. Amsterdam, the Netherlands: Elsevier, 1997: 263-375.
32. Björklund A, Dunnett SB,. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30: 194-202. (Pubitemid 46654237)
33. Zecca L, Youdim MB, Riederer P, et al. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004; 5: 863-873. (Pubitemid 39482155)
34. Berg D, Youdim MB,. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 2006; 17: 5-17. (Pubitemid 46672929)
35. Fasano M, Bergamasco B, Lopiano L,. Modifications of the iron-neuromelanin system in Parkinson's disease. J Neurochem 2006; 96: 909-916.
36. Jellinger KA, Kienzl E, Rumpelmaier G, et al. Iron and ferritin in substantia nigra in Parkinson's disease. Adv Neurol 1993; 60: 267-272.
37. Gerlach M, Double KL, Youdim MB, Riederer P,. Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl 2006; (70): 133-142. (Pubitemid 44622190)
38. Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 2006; 17: 1215-1218. (Pubitemid 44051416)
39. Shibata E, Sasaki M, Tohyama K, et al. Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 2008; 64: 401-406.
40. Adachi M, Hosoya T, Haku T, et al. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am J Neuroradiol 1999; 20: 1500-1506. (Pubitemid 29455875)
41. Hutchinson M, Raff U,. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. AJNR Am J Neuroradiol 2000; 21: 697-701. (Pubitemid 30210433)
42. Manova ES, Habib CA, Boikov AS, et al. Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2009; 30: 569-574.
43. Menke RA, Jbabdi S, Miller KL, et al. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage 2010; 52: 1175-1180.
44. Duguid JR, De La Paz R, DeGroot J,. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986; 20: 744-747. (Pubitemid 17207654)
45. Stern MB, Braffman BH, Skolnick BE, et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989; 39: 1524-1526. (Pubitemid 19286015)
46. Huber SJ, Chakeres DW, Paulson GW, Khanna R,. Magnetic resonance imaging in Parkinson's disease. Arch Neurol 1990; 47: 735-737. (Pubitemid 20208611)
47. Pujol J, Junqué C, Vendrell P, et al. Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease. Arch Neurol 1992; 49: 1119-1122.
48. Doraiswamy PM, Shah SA, Husain MM, et al. Magnetic resonance evaluation of the midbrain in Parkinson's disease. Arch Neurol 1991; 48: 360.
49. Ryvlin P, Broussolle E, Piollet H, et al. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. Arch Neurol 1995; 52: 583-588.
50. Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999; 17: 213-222. (Pubitemid 29053180)
51. Massey LA, Yousry TA,. Anatomy of the substantia nigra and subthalamic nucleus on MR imaging. Neuroimaging Clin N Am 2010; 20: 7-27.
52. Schoene WC,. Degenerative diseases of the central nervous system. In:, Davis AL, Robertson DM, editors. Textbook of neuropathology. Baltimore, MD: Williams & Wilkins, 1985: 788-823.
53. Dexter DT, Sian J, Jenner P, Marsden CD,. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. Adv Neurol 1993; 60: 273-281.
54. Tamraz JC, Comair YG,. Atlas of regional anatomy of the brain using MRI. Berlin, Germany: Springer, 2000.